The Latest Headlines at Zolmax
Plains All American Pipeline (NYSE:PAA) Raised to “Hold” at Zacks Investment Research
Plains All American Pipeline (NYSE:PAA) was upgraded by Zacks Investment Research from a “strong sell” rating to a “hold” rating in a research report issued on Wednesday, Zacks.com reports. The brokerage currently... More of this article »
Lithium Americas (NYSE:LAC) Lifted to Buy at Zacks Investment Research
Zacks Investment Research upgraded shares of Lithium Americas (NYSE:LAC) from a hold rating to a buy rating in a report released on Tuesday, Zacks.com reports. They currently have $29.00 price objective on the stock. According to... More of this article »
Zacks Investment Research Downgrades Genesis Energy (NYSE:GEL) to Strong Sell
Genesis Energy (NYSE:GEL) was downgraded by Zacks Investment Research from a “hold” rating to a “strong sell” rating in a research note issued to investors on Wednesday, Zacks.com reports. According to Zacks,... More of this article »
INVO Bioscience (NASDAQ:INVO) Lifted to Hold at Zacks Investment Research
Zacks Investment Research upgraded shares of INVO Bioscience (NASDAQ:INVO) from a sell rating to a hold rating in a research note published on Tuesday morning, Zacks.com reports. According to Zacks, “INVO Bioscience is a medical... More of this article »
Vanguard Group Inc. Boosts Stake in Ameris Bancorp (NASDAQ:ABCB)
Vanguard Group Inc. increased its stake in shares of Ameris Bancorp (NASDAQ:ABCB) by 3.4% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 7,402,155... More of this article »
Old Dominion Freight Line (NASDAQ:ODFL) PT Raised to $300.00 at Bank of America
Old Dominion Freight Line (NASDAQ:ODFL) had its price objective upped by Bank of America from $250.00 to $300.00 in a report issued on Tuesday, The Fly reports. They currently have an underperform rating on the transportation company’s... More of this article »
Editas Medicine (NASDAQ:EDIT) Earns Market Perform Rating from Analysts at SVB Leerink
SVB Leerink assumed coverage on shares of Editas Medicine (NASDAQ:EDIT) in a research report released on Tuesday, Analyst Price Targets reports. The firm issued a market perform rating and a $41.00 target price on the stock. SVB Leerink... More of this article »
CommScope Holding Company, Inc. (NASDAQ:COMM) Shares Purchased by Dimensional Fund Advisors LP
Dimensional Fund Advisors LP boosted its position in CommScope Holding Company, Inc. (NASDAQ:COMM) by 8.4% during the second quarter, Holdings Channel.com reports. The institutional investor owned 1,710,689 shares of the communications... More of this article »
Credit Suisse Group (NYSE:CS) Upgraded at Cheuvreux
Cheuvreux upgraded shares of Credit Suisse Group (NYSE:CS) from a hold rating to a buy rating in a research report report published on Tuesday, The Fly reports. Several other equities research analysts have also recently commented... More of this article »
Zacks Investment Research Lowers Sunstone Hotel Investors (NYSE:SHO) to Hold
Sunstone Hotel Investors (NYSE:SHO) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued on Wednesday, Zacks.com reports. According to Zacks, “Sunstone... More of this article »
Stephens Increases Canadian National Railway (NYSE:CNI) Price Target to $126.00
Canadian National Railway (NYSE:CNI) (TSE:CNR) had its price objective hoisted by equities research analysts at Stephens from $120.00 to $126.00 in a research report issued on Wednesday, Benzinga reports. The brokerage currently has... More of this article »
Stephens Increases Canadian National Railway (NYSE:CNI) Price Target to $126.00
Canadian National Railway (NYSE:CNI) (TSE:CNR) had its price objective increased by research analysts at Stephens from $120.00 to $126.00 in a research note issued on Wednesday, Benzinga reports. The brokerage presently has an “equal... More of this article »
Avalara, Inc. (NYSE:AVLR) Given Consensus Recommendation of “Buy” by Analysts
Shares of Avalara, Inc. (NYSE:AVLR) have been given an average recommendation of “Buy” by the sixteen research firms that are covering the stock, Marketbeat.com reports. Two analysts have rated the stock with a hold rating... More of this article »